You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 241 No. 10, March 9, 1979 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lithium Prophylaxis of Corticotropin-lnduced Psychosis

William E. Falk, MD; Mark W. Mahnke, MD; David C. Poskanzer, MD

JAMA. 1979;241(10):1011-1012.


Abstract

Corticotropin is one of the few accepted treatments for acute exacerbations of multiple sclerosis and retrobulbar neuritis. Psychosis is a serious side effect usually necessitating discontinuation of the drug therapy. Because mood disorders preponderated in most patients previously described with this psychosis, 27 patients were empirically treated with lithium carbonate concurrently with corticotropin. In none of the patients treated with lithium did a psychotic reaction occur, although in a comparable group of 44 patients previously treated identically with corticotropin but without lithium, six (14%) became psychotic.

(JAMA 241:1011-1012, 1979)



Author Affiliations

From the Departments of Psychiatry (Dr Falk) and Neurology (Dr Poskanzer), Massachusetts General Hospital, Boston; the Department of Psychiatry (Dr Mahnke), McLean Hospital, Boston; and the Departments of Psychiatry (Drs Falk and Mahnke) and Neurology (Dr Poskanzer), Harvard Medical School, Boston.


Footnotes

Reprint requests to Department of Neurology, Massachusetts General Hospital, Boston, MA 02114 (Dr Poskanzer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psychiatric Adverse Effects of Corticosteroids
Warrington and Bostwick
Mayo Clin Proc. 2006;81:1361-1367.
ABSTRACT | FULL TEXT  

Corticosteroid-Induced Psychotic and Mood Disorders: Diagnosis Defined by DSM-IV and Clinical Pictures
Wada et al.
Psychosomatics 2001;42:461-466.
ABSTRACT | FULL TEXT  

Case 35-1998: Use of Lithium to Prevent Corticosteroid-Induced Mania
Merrill
NEJM 1999;340:1123-1123.
FULL TEXT  

Mental Status Changes in Children Receiving Glucocorticoids: Review of the Literature
Satel
CLIN PEDIATR 1990;29:382-388.
ABSTRACT  

Psychiatric Aspects of Organ Transplantation
Wise et al.
JAMA 1988;260:3437-3437.
ABSTRACT  

Relationship Between Alternate-Day Corticosteroid Therapy and Behavioral Abnormalities
Sharfstein et al.
JAMA 1982;248:2987-2989.
ABSTRACT  

Organic Brain Syndromes
McEVOY
ANN INTERN MED 1981;95:212-220.
ABSTRACT  

Side Effects of Corticosteroid Therapy: Psychiatric Aspects
Ling et al.
Arch Gen Psychiatry 1981;38:471-477.
ABSTRACT  

Psychiatric Medicine: An Annotated Bibliography of Recent Literature
CASSEM et al.
ANN INTERN MED 1980;92:444-450.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.